Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.

Numerous factors impact on the prognosis of acute myeloid leukemia (AML), among which molecular genetic abnormalities are developed increasingly, however, accurate prediction for newly diagnosed AML patients remains unsatisfied. For further improving the prognosis evaluation system, we investigated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yiming Tian, Zoufang Huang, Zhixiang Wang, Changxin Yin, Lanlan Zhou, Lingxiu Zhang, Kaikai Huang, Hongsheng Zhou, Xuejie Jiang, Jinming Li, Libin Liao, Mo Yang, Fanyi Meng
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6ef8c19092c240e597b80ebbcde457bb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6ef8c19092c240e597b80ebbcde457bb
record_format dspace
spelling oai:doaj.org-article:6ef8c19092c240e597b80ebbcde457bb2021-11-18T08:38:36ZIdentification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.1932-620310.1371/journal.pone.0084150https://doaj.org/article/6ef8c19092c240e597b80ebbcde457bb2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24416201/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Numerous factors impact on the prognosis of acute myeloid leukemia (AML), among which molecular genetic abnormalities are developed increasingly, however, accurate prediction for newly diagnosed AML patients remains unsatisfied. For further improving the prognosis evaluation system, we investigated the transcripts levels of PDCD7, FIS1, FAM3A, CA6, APP, KLRF1, ATCAY, GGT5 and Ang2 in 97 AML patients and 30 non-malignant controls, and validated using the published microarray data from 225 cytogenetically normal AML (CN-AML) patients treated according to the German AMLCG-1999 protocol. Real-time quantitative polymerase chain reaction and western blot were carried out, and clinical data were collected and analyzed. High Ang2 and FIS1 expression discriminated the CR rate of AML patients (62.5% versus 82.9% for Ang2, P = 0.011; 61.4% versus 82.2% for FIS1, P = 0.029). In CN-AML, patients with high FIS1 expression were more likely to be resistant to two courses of induction (P = 0.035). Overall survival (OS) and relapse-free survival (RFS) were shorter in CN-AML patients with high PDCD7 expression (P<0.001; P = 0.006), and PDCD7 was revealed to be an independent risk factor for OS in CN-AML (P = 0.004). In the analysis of published data from 225 CN-AML patients, PDCD7 remained independently predicting OS in CN-AML (P = 0.039). As a conclusion, Ang2 and FIS1 seem related to decreased CR rate of AML patients, and PDCD7 is associated with shorter OS and RFS in CN-AML. Hence, PDCD7, Ang2 and FIS1 may indicate a more aggressive form and poor prognosis of AML.Yiming TianZoufang HuangZhixiang WangChangxin YinLanlan ZhouLingxiu ZhangKaikai HuangHongsheng ZhouXuejie JiangJinming LiLibin LiaoMo YangFanyi MengPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 1, p e84150 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yiming Tian
Zoufang Huang
Zhixiang Wang
Changxin Yin
Lanlan Zhou
Lingxiu Zhang
Kaikai Huang
Hongsheng Zhou
Xuejie Jiang
Jinming Li
Libin Liao
Mo Yang
Fanyi Meng
Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
description Numerous factors impact on the prognosis of acute myeloid leukemia (AML), among which molecular genetic abnormalities are developed increasingly, however, accurate prediction for newly diagnosed AML patients remains unsatisfied. For further improving the prognosis evaluation system, we investigated the transcripts levels of PDCD7, FIS1, FAM3A, CA6, APP, KLRF1, ATCAY, GGT5 and Ang2 in 97 AML patients and 30 non-malignant controls, and validated using the published microarray data from 225 cytogenetically normal AML (CN-AML) patients treated according to the German AMLCG-1999 protocol. Real-time quantitative polymerase chain reaction and western blot were carried out, and clinical data were collected and analyzed. High Ang2 and FIS1 expression discriminated the CR rate of AML patients (62.5% versus 82.9% for Ang2, P = 0.011; 61.4% versus 82.2% for FIS1, P = 0.029). In CN-AML, patients with high FIS1 expression were more likely to be resistant to two courses of induction (P = 0.035). Overall survival (OS) and relapse-free survival (RFS) were shorter in CN-AML patients with high PDCD7 expression (P<0.001; P = 0.006), and PDCD7 was revealed to be an independent risk factor for OS in CN-AML (P = 0.004). In the analysis of published data from 225 CN-AML patients, PDCD7 remained independently predicting OS in CN-AML (P = 0.039). As a conclusion, Ang2 and FIS1 seem related to decreased CR rate of AML patients, and PDCD7 is associated with shorter OS and RFS in CN-AML. Hence, PDCD7, Ang2 and FIS1 may indicate a more aggressive form and poor prognosis of AML.
format article
author Yiming Tian
Zoufang Huang
Zhixiang Wang
Changxin Yin
Lanlan Zhou
Lingxiu Zhang
Kaikai Huang
Hongsheng Zhou
Xuejie Jiang
Jinming Li
Libin Liao
Mo Yang
Fanyi Meng
author_facet Yiming Tian
Zoufang Huang
Zhixiang Wang
Changxin Yin
Lanlan Zhou
Lingxiu Zhang
Kaikai Huang
Hongsheng Zhou
Xuejie Jiang
Jinming Li
Libin Liao
Mo Yang
Fanyi Meng
author_sort Yiming Tian
title Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
title_short Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
title_full Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
title_fullStr Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
title_full_unstemmed Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
title_sort identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of pdcd7, fis1 and ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/6ef8c19092c240e597b80ebbcde457bb
work_keys_str_mv AT yimingtian identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT zoufanghuang identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT zhixiangwang identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT changxinyin identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT lanlanzhou identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT lingxiuzhang identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT kaikaihuang identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT hongshengzhou identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT xuejiejiang identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT jinmingli identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT libinliao identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT moyang identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
AT fanyimeng identificationofnovelmolecularmarkersforprognosisestimationofacutemyeloidleukemiaoverexpressionofpdcd7fis1andang2mayindicatepoorprognosisinpretreatmentpatientswithacutemyeloidleukemia
_version_ 1718421505737490432